The trial results looked at liraglutide, the active ingredient in two of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a diabetes drug. In a late-stage clinical trial, a ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...
The Yale team defined BMI-defined obesity using well-established threshold set by the Centers for Disease Control and Prevention and the American Academy of Pediatric ...
Adolescents who achieved a BMI reduction of at least 10% at 26 weeks with a reduced-calorie diet had significant decreases in ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback